Phase II study of tamoxifen in patients with advanced renal cell carcinoma

Cancer Treat Rep. 1980 Feb-Mar;64(2-3):343-4.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / pathology
  • Aged
  • Drug Evaluation
  • Female
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / pathology
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Prognosis
  • Tamoxifen / therapeutic use*

Substances

  • Tamoxifen